跳转至内容
Merck
所有图片(3)

文件

228435

Sigma-Aldrich

5-溴吡啶-3-羧酸

98%

别名:

5-溴烟酸

登录查看公司和协议定价
所有图片(3)

About This Item

经验公式（希尔记法）:
C6H4BrNO2
CAS号:
20826-04-4
分子量:
202.01
Beilstein:
115854
EC號碼:
244-065-5
MDL號碼:
MFCD00009783
分類程式碼代碼:
12352100
PubChem物質ID:
24853685
NACRES:
NA.22

化驗

98%

形狀

solid

mp

178-180 °C (lit.)

SMILES 字串

OC(=O)c1cncc(Br)c1

InChI

1S/C6H4BrNO2/c7-5-1-4(6(9)10)2-8-3-5/h1-3H,(H,9,10)

InChI 密鑰

FQIUCPGDKPXSLL-UHFFFAOYSA-N

正在寻找类似产品? 访问 产品对比指南

相关类别

應用

5-溴吡啶-3-羧酸（5-溴烟酸）用于合成3-胍基甲基-5-碘吡啶。

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 3

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

G Vaidyanathan et al.
Bioconjugate chemistry, 9(6), 758-764 (1998-11-17)
Substituting a pyridine ring for a benzene ring in the acylation agent N-succinimidyl 3-iodobenzoate has resulted in a useful approach for the radiohalogenation of monoclonal antibodies, peptides, and labeled biotin conjugates. It was hypothesized that such a substitution in m-iodobenzylguanidine
Małgorzata Dukat et al.
European journal of pharmacology, 435(2-3), 171-180 (2002-02-01)
Two 5-substituted derivatives of nicotine (nicotinic acetylcholine receptor: K(i)=2.4 nM) were synthesized and evaluated: 5-bromonicotine (K(i)=6.9 nM) and 5-methoxynicotine (K(i)=14.3 nM). Despite their high affinity, neither 5-bromonicotine nor 5-methoxynicotine mimicked nicotine in producing antinociceptive (tail-flick, hotplate), hypolocomotor, or hypothermic effects
F Gabor et al.
Journal of pharmaceutical sciences, 84(9), 1120-1125 (1995-09-01)
Two types of monoclonal antibodies were used for the determination of nicergoline in biological matrices. The antibodies were prepared with the hydrolysis products 5-bromonicotinic acid and 1-methyl-10 alpha-methoxydihydrolysergol after hemisuccinoylation to haptens. The current amide bond-generating methods (mixed anhydride-, carbodiimide-
Tawfik Gharbaoui et al.
Bioorganic & medicinal chemistry letters, 17(17), 4914-4919 (2007-06-26)
A strategy for lead identification of new agonists of GPR109a, starting from known compounds shown to activate the receptor, is described. Early compound triage led to the formulation of a binding hypothesis and eventually to our focus on a series

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门